You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
|
|---|---|
| Published in |
Frontiers in immunology, March 2016
|
| DOI | 10.3389/fimmu.2016.00123 |
| Pubmed ID | |
| Authors |
Verena Katharina Raker, Christian Becker, Kerstin Steinbrink |
| Abstract |
Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effects have immunoregulatory potential in autoimmune and inflammatory disorders. Here, we provide an overview of the cyclic AMP axis and its role as a regulator of immune functions and discuss the clinical and translational relevance of interventions with these processes. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Spain | 1 | 25% |
| Switzerland | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 305 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Unknown | 304 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 53 | 17% |
| Student > Bachelor | 44 | 14% |
| Student > Master | 40 | 13% |
| Researcher | 35 | 11% |
| Other | 16 | 5% |
| Other | 35 | 11% |
| Unknown | 82 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 60 | 20% |
| Agricultural and Biological Sciences | 33 | 11% |
| Immunology and Microbiology | 26 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 8% |
| Medicine and Dentistry | 22 | 7% |
| Other | 51 | 17% |
| Unknown | 89 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2022.
All research outputs
#2,876,598
of 25,461,852 outputs
Outputs from Frontiers in immunology
#2,992
of 31,698 outputs
Outputs of similar age
#45,258
of 315,558 outputs
Outputs of similar age from Frontiers in immunology
#12
of 145 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,698 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,558 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 145 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.